Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 6Terminated 2Active not recruiting 2Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 53Other 1Gynecologic 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 132Ovarian Neoplasms 109Endometrial Neoplasms 81Uterine Cervical Dysplasia 19Papillomavirus Infections 17Breast Neoplasms 17Fallopian Tube Neoplasms 15Carcinoma, Ovarian Epithelial 15Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 12Neoplasms 11Vulvar Neoplasms 10Neoplasm Metastasis 10Recurrence 9Prostatic Neoplasms 9Endometrial Hyperplasia 9Cervical Cancer Screening 9Acquired Immunodeficiency Syndrome 8Uterine Neoplasms 7Stomach Neoplasms 7Squamous Intraepithelial Lesions 6Locally Advanced Cervical Cancer 6Anus Neoplasms 6Vaginal Neoplasms 5Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pelvic Neoplasms 5Pancreatic Neoplasms 5Melanoma 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nasopharyngeal Carcinoma × Gynecologic × Clear all
NCT06383507 2024-04-25

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Zhejiang University

Phase 1 Not yet recruiting
18 enrolled
GenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡